Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MEX3A-mediated super-enhancer RNA m6A methylation promotes aggressiveness of breast cancer via regulating RBM15B/IGF2BP3/KMT2C signaling. | Transl Oncol | 2026 | 41161249 | PubTator, text mining | PubMed |
| circTGFBR2(3-6) acts as an assembly platform for RNA-binding protein IGF2BP3 and TGFBR1 mRNA to enhance breast cancer cell plasticity. | Cell Death Differ | 2026 | 41145815 | PubTator, text mining | PubMed |
| CCL25 Stabilized by IGF2BP3 Induces Cellular Oxidative Stress to Promote Septic Lung Injury. | Tohoku J Exp Med | 2026 | 41125359 | PubTator, text mining | PubMed |
| METTL3/IGF2BP3 axis promotes gemcitabine resistance of pancreatic cancer cells through regulating USP33-mediated PAK1 deubiquitination and degradation. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41108357 | PubTator, text mining | PubMed |
| IGF2BP3-mediated NTSR1 m6A methylation enhances irinotecan resistance and lung adenocarcinoma malignant progression. | Am J Respir Cell Mol Biol | 2026 | 40986744 | PubTator, text mining | PubMed |
| m6A-modified circCD2AP suppressed ferroptosis in bladder cancer by upregulating FOXC1 to promote PARK7 transcriptional activity. | Chin Med J (Engl) | 2026 | 40960159 | PubTator, text mining | PubMed |
| Construction of a Single-cell Atlas of Thyroid Cancer | Endocr Metab Immune Disord Drug Targets | 2026 | 40183263 | PubTator, text mining | PubMed |
| Regulation of Energy Metabolism and Lipid Metabolites by IMP3 in Cervical Cancer. | Curr Issues Mol Biol | 2025 | 41614778 | PubTator, text mining | PubMed |
| Identification of IGF2BP3 and CENPA as key regulators of immunophenotypes in renal clear cell carcinoma. | Front Genet | 2025 | 41589308 | PubTator, text mining | PubMed |
| Integrated network toxicology, machine learning algorithms and TMT proteomics reveal the mechanism of 18β glycyrrhetinic acid against gastric cancer. | Front Genet | 2025 | 41561975 | PubTator, text mining | PubMed |
| IGF2BP3 binds to FBXO32 to activate the cyclic guanosine monophosphate-protein kinase G pathway, promoting gastric cancer progression. | World J Gastroenterol | 2025 | 41479643 | PubTator, text mining | PubMed |
| Harnessing m6A-regulated cholesterol biosynthesis helps impede tumor burden and stemness in high-garde serous ovarian carcinoma mesenchymal phenotype. | Mol Med | 2025 | 41466215 | PubTator, text mining | PubMed |
| IGF2BP3-STAT3-METTL3 axis promotes malignant progression in hepatocellular carcinoma (HCC). | Hum Genomics | 2025 | 41449478 | PubTator, text mining | PubMed |
| METTL3 mediates m6A methylation of LCN2 through IGF2BP3 to promote ferroptosis in chronic obstructive pulmonary disease. | Hereditas | 2025 | 41449458 | PubTator, text mining | PubMed |
| TRIM21 promotes K63-linked ubiquitination of ALKBH5 and suppresses cuproptosis via down-regulation of LIAS in esophageal squamous cell carcinoma. | Commun Biol | 2025 | 41413718 | PubTator, text mining | PubMed |
| The cancer-testis lncRNA LINC01940 promotes gastric cancer malignant progression and chemoresistance by enhancing ribosome biogenesis via TAF15-mediated NOL11 SUMOylation. | Cell Mol Biol Lett | 2025 | 41402710 | PubTator, text mining | PubMed |
| A cancer-testis antigen signature for predicting prognosis and response to immunotherapy in acute myeloid leukemia. | Medicine (Baltimore) | 2025 | 41398765 | PubTator, text mining | PubMed |
| IGF2BPs directly regulate the noncanonical translation of toxic proteins from mutant FMR1 mRNA containing expanded CGG repeats. | Nat Commun | 2025 | 41372183 | PubTator, text mining | PubMed |
| Asparagine endopeptidase prompts breast cancer-related pericardial calcification by regulating IGF2 and integrin αvβ5. | Proc Natl Acad Sci U S A | 2025 | 41343669 | PubTator, text mining | PubMed |
| Revolutionizing Thyroid Cancer Diagnosis: The Role of THADA-IGF2BP3 Fusions in Identifying Indolent Neoplasms. | J Cytol | 2025 | 41341476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=8